These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30107765)

  • 1. Screening for spinal muscular atrophy.
    Sampaio H; Wilcken B; Farrar M
    Med J Aust; 2018 Aug; 209(4):147-148. PubMed ID: 30107765
    [No Abstract]   [Full Text] [Related]  

  • 2. Spinal Muscular Atrophy in the Treatment Era.
    Waldrop MA; Elsheikh BH
    Neurol Clin; 2020 Aug; 38(3):505-518. PubMed ID: 32703464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maximising returns: combining newborn screening with gene therapy for spinal muscular atrophy.
    Gillingwater TH
    J Neurol Neurosurg Psychiatry; 2021 Dec; 92(12):1252. PubMed ID: 34321342
    [No Abstract]   [Full Text] [Related]  

  • 4. Willingness to Pay for a Newborn Screening Test for Spinal Muscular Atrophy.
    Lin PJ; Yeh WS; Neumann PJ
    Pediatr Neurol; 2017 Jan; 66():69-75. PubMed ID: 27769729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Infantile spinal atrophy: our experience in the last 25 years].
    Madrid Rodríguez A; Martínez Martínez PL; Ramos Fernández JM; Urda Cardona A; Martínez Antón J
    An Pediatr (Barc); 2015 Mar; 82(3):159-65. PubMed ID: 25103837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinal Muscular Atrophy.
    Nicolau S; Waldrop MA; Connolly AM; Mendell JR
    Semin Pediatr Neurol; 2021 Apr; 37():100878. PubMed ID: 33892848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of an interest in spinal muscular atrophy and disabilities.
    Russman BS
    Dev Med Child Neurol; 2005 Sep; 47(9):579. PubMed ID: 16138661
    [No Abstract]   [Full Text] [Related]  

  • 8. Interventions for spinal muscular atrophy: an impetus for newborn screening.
    EBioMedicine; 2021 Jul; 69():103507. PubMed ID: 34315607
    [No Abstract]   [Full Text] [Related]  

  • 9. Newborn genetic screening for spinal muscular atrophy in the UK: The views of the general population.
    Boardman FK; Sadler C; Young PJ
    Mol Genet Genomic Med; 2018 Jan; 6(1):99-108. PubMed ID: 29169204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating neonatal spinal muscular atrophy: A 21st century success story?
    Tizzano EF
    Early Hum Dev; 2019 Nov; 138():104851. PubMed ID: 31604576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinal muscular atrophy.
    Wessel HB
    Pediatr Ann; 1989 Jul; 18(7):421-7. PubMed ID: 2666923
    [No Abstract]   [Full Text] [Related]  

  • 12. Controversy over Werdnig-Hoffmann disease and multiple system atrophy.
    Chou SM
    Curr Opin Neurol; 1993 Dec; 6(6):861-4. PubMed ID: 8293160
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnosis and New Treatment Avenues in Spinal Muscular Atrophy.
    Pechmann A; Kirschner J
    Neuropediatrics; 2017 Aug; 48(4):273-281. PubMed ID: 28571100
    [No Abstract]   [Full Text] [Related]  

  • 14. Case of paediatric neuromuscular disease with a surprising clinical outcome: time to challenge the dogma?
    Wright M; Manzur A; Bush A
    Thorax; 2018 Aug; 73(8):788-790. PubMed ID: 29382800
    [No Abstract]   [Full Text] [Related]  

  • 15. Gene therapy rescues newborns with spinal muscular atrophy.
    Sheridan C
    Nat Biotechnol; 2018 Aug; 36(8):669-670. PubMed ID: 30080825
    [No Abstract]   [Full Text] [Related]  

  • 16. Ontario Newborn Screening for Spinal Muscular Atrophy: The First Year.
    Kernohan KD; McMillan HJ; Yeh E; Lacaria M; Kowalski M; Campbell C; Dowling JJ; Gonorazky H; Marcadier J; Tarnopolsky MA; Vajsar J; Mackenzie A; Chakraborty P
    Can J Neurol Sci; 2022 Nov; 49(6):821-823. PubMed ID: 34620260
    [No Abstract]   [Full Text] [Related]  

  • 17. [Distal spinal-muscular atrophy 1 (DSMA1 or SMARD1)].
    Kaindl AM; Guenther UP; Rudnik-Schöneborn S; Varon R; Zerres K; Gressens P; Schuelke M; Hubner C; von Au K
    Arch Pediatr; 2008 Oct; 15(10):1568-72. PubMed ID: 18804971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinal muscular atrophy: clinical classification and disease heterogeneity.
    Russman BS
    J Child Neurol; 2007 Aug; 22(8):946-51. PubMed ID: 17761648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic nature of spinal muscular atrophy revealed by studying insurance claims.
    Lipnick SL; Agniel DM; Aggarwal R; Makhortova NR; Finlayson SG; Brocato A; Palmer N; Darras BT; Kohane I; Rubin LL
    PLoS One; 2019; 14(3):e0213680. PubMed ID: 30870495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zolgensma - one-time gene therapy for spinal muscular atrophy.
    Med Lett Drugs Ther; 2019 Jul; 61(1577):113-114. PubMed ID: 31381549
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.